These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 37150853)

  • 1. Clinical outcomes of chemotherapy in cancer patients with different ethnicities.
    Pathak S; Zajac KK; Annaji M; Govindarajulu M; Nadar RM; Bowen D; Babu RJ; Dhanasekaran M
    Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1830. PubMed ID: 37150853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.
    O'Donnell PH; Dolan ME
    Clin Cancer Res; 2009 Aug; 15(15):4806-14. PubMed ID: 19622575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer pharmacogenomics: implications on ethnic diversity and drug response.
    Patel JN
    Pharmacogenet Genomics; 2015 May; 25(5):223-30. PubMed ID: 25751395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.
    Narendra G; Choudhary S; Raju B; Verma H; Silakari O
    Clin Pharmacokinet; 2022 Nov; 61(11):1495-1517. PubMed ID: 36180817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development.
    Lee W; Lockhart AC; Kim RB; Rothenberg ML
    Oncologist; 2005 Feb; 10(2):104-11. PubMed ID: 15709212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
    Chen ML
    Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy.
    Li J; Bluth MH
    Pharmgenomics Pers Med; 2011; 4():11-33. PubMed ID: 23226051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
    Bosch TM; Meijerman I; Beijnen JH; Schellens JH
    Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer.
    Han HS; Reis IM; Zhao W; Kuroi K; Toi M; Suzuki E; Syme R; Chow L; Yip AY; Glück S
    Eur J Cancer; 2011 Nov; 47(17):2537-45. PubMed ID: 21741825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-ethnic differences in pharmacokinetics-is there more that unites than divides?
    Olafuyi O; Parekh N; Wright J; Koenig J
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00890. PubMed ID: 34725944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs.
    Phan VH; Tan C; Rittau A; Xu H; McLachlan AJ; Clarke SJ
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1395-410. PubMed ID: 21950349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Polymorphisms in Pharmaceuticals and Chemotherapy.
    Gummadi AC; Guddati AK
    World J Oncol; 2021 Oct; 12(5):149-154. PubMed ID: 34804277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of drug-metabolising enzymes in clinical responses to chemotherapy.
    Scripture CD; Figg WD; Sparreboom A
    Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):17-25. PubMed ID: 16863465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer pharmacogenomics: achievements in basic research.
    Nakajima M; Yokoi T
    Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer pharmacogenomics: international trends.
    Yamayoshi Y; Iida E; Tanigawara Y
    Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic databases in pharmacogenomics: the Frequency of Inherited Disorders Database (FINDbase).
    Georgitsi M; Patrinos GP
    Methods Mol Biol; 2013; 1015():321-36. PubMed ID: 23824866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The era of genomics: impact on sepsis clinical trial design.
    Cariou A; Chiche JD; Charpentier J; Dhainaut JF; Mira JP
    Crit Care Med; 2002 May; 30(5 Suppl):S341-8. PubMed ID: 12004257
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.